Zobrazeno 1 - 10
of 66
pro vyhledávání: '"JA Erkens"'
Publikováno v:
Van Der Linden, M W, Plat, A W, Erkens, J A, Emneus, M & Herings, R M C 2009, ' Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in the Netherlands during 2000 to 2004 ', Value in Health, vol. 12, no. 6, pp. 909-914 . https://doi.org/10.1111/j.1524-4733.2009.00506.x
Value in Health, 12(6), 909-914. Elsevier Limited
Value in Health, 12(6), 909-914. Elsevier Limited
Objective To estimate the burden of diabetes mellitus (DM) and its complications in The Netherlands. Methods The PHARMO Record Linkage System comprised among others linked drug dispensing, hospital and clinical laboratory data from approximately 2.5
Publikováno v:
Penning-van Beest, F J A, Erkens, J A, Olson, M & Herings, R M C 2008, ' Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis ', Current Medical Research and Opinion, vol. 24, no. 5, pp. 1337-1344 . https://doi.org/10.1185/030079908X297358
Current Medical Research and Opinion, 24(5), 1337-1344. Taylor and Francis Ltd.
Current Medical Research and Opinion, 24(5), 1337-1344. Taylor and Francis Ltd.
Objective: To identify determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis. By considering the year of the introduction of weekly bisphosphonates important additional information is obtained. Methods: New fem
Autor:
René Aalbers, Marjo J T van de Ven, JA Erkens, NS Breekveldt-Postma, Ron M. C. Herings, Jan-Willem J. Lammers
Publikováno v:
Current Medical Research and Opinion. 24:975-983
Asthma is a major public health problem with considerable economic impact. The highest costs being observed in patients with severe asthma. Furthermore, despite the use of recommended therapies, asthma control can still be poor. Therefore, the object
Publikováno v:
Pharmacoepidemiology and Drug Safety, 17(1), 9-19. John Wiley and Sons Ltd
Sukel, M P P, van der Linden, M W, Chen, C, Erkens, J A & Herings, R M C 2008, ' Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal ', Pharmacoepidemiology and Drug Safety, vol. 17, no. 1, pp. 9-19 . https://doi.org/10.1002/pds.1508
Sukel, M P P, van der Linden, M W, Chen, C, Erkens, J A & Herings, R M C 2008, ' Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal ', Pharmacoepidemiology and Drug Safety, vol. 17, no. 1, pp. 9-19 . https://doi.org/10.1002/pds.1508
Purpose To compare treatment changes after the rofecoxib withdrawal with changes occurring normally and to re-assess 12 months afterwards. Methods The PHARMO database comprised medication and hospital discharge records of over 3 million inhabitants i
Autor:
Paul D. van der Linden, NS Breekveldt-Postma, Annette B. Beiderbeck, JA Erkens, Jan Willem Coebergh, Myrthe P. P. Sukel, Ron M. C. Herings
Publikováno v:
Pharmacoepidemiology and Drug Safety. 17:125-134
Purpose To assess the incidence of cardiovascular events among breast cancer patients after chemotherapy. Methods Women ≥18 years with a breast tumour who received chemotherapy in 1992–2003 were selected from the PHARMO RLS. Chemotherapy with ant
Autor:
JA Erkens, J. John Mann, Ron M. C. Herings, Dulal K. Bhaumik, Kwan Hur, Sue M. Marcus, Robert D. Gibbons, C. Hendricks Brown
Publikováno v:
American Journal of Psychiatry. 164:1356-1363
In 2003 and 2004, U.S. and European regulators issued public health warnings about a possible association between antidepressants and suicidal thinking and behavior. The authors assessed whether these warnings discouraged use of antidepressants in ch
Publikováno v:
Clinical Therapeutics, 28(2), 236-242. Excerpta Medica
Penning-van Beest, F J A, Goettsch, W G, Erkens, J A & Herings, R M C 2006, ' Determinants of persistence with bisphosphonates : A study in women with postmenopausal osteoporosis ', Clinical Therapeutics, vol. 28, no. 2, pp. 236-242 . https://doi.org/10.1016/j.clinthera.2006.01.002
Penning-van Beest, F J A, Goettsch, W G, Erkens, J A & Herings, R M C 2006, ' Determinants of persistence with bisphosphonates : A study in women with postmenopausal osteoporosis ', Clinical Therapeutics, vol. 28, no. 2, pp. 236-242 . https://doi.org/10.1016/j.clinthera.2006.01.002
Background: Although bisphosphonates are useful in the management of osteoporosis, patients often discontinue treatment. Objectives: The aims of this study were to investigate persistence with bisphosphonates, and to assess whether the dose interval
Autor:
Diederick E. Grobbee, Ronald P. Stolk, JA Erkens, José A. Spoelstra, Hubert G. M. Leufkens, Olaf H. Klungel
Publikováno v:
Pharmacoepidemiology and Drug Safety. 13:139-146
Purpose The objective of this study was to determine the association between different antihypertensive drug therapies and lower extremity amputations (LEAs) in type 2 diabetes patients. Methods Data were obtained from the PHARMO Record Linkage Syste
Autor:
Olaf H. Klungel, José A. Spoelstra, D. E. Grobbee, JA Erkens, R. M. C. Herings, Hubert G. M. Leufkens, Ronald P. Stolk
Publikováno v:
European Heart Journal, 23(20), 1575-1579. Oxford University Press
Erkens, J A, Klungel, O H, Herings, R M, Stolk, R P, Spoelstra, J A, Grobbee, D E & Leufkens, H G 2002, ' Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients ', European Heart Journal, vol. 23, no. 20, pp. 1575-1579 . https://doi.org/10.1053/euhj.2002.3173
Erkens, J A, Klungel, O H, Herings, R M, Stolk, R P, Spoelstra, J A, Grobbee, D E & Leufkens, H G 2002, ' Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients ', European Heart Journal, vol. 23, no. 20, pp. 1575-1579 . https://doi.org/10.1053/euhj.2002.3173
Aims The aim of the present study was to investigate whether use of specific antibiotic drugs decreases the risk of coronary heart disease in diabetes mellitus type 2 patients. Methods and Results Data were obtained from the PHARMO Record Linkage Sys
Autor:
José A. Spoelstra, JA Erkens, Diederick E. Grobbee, Ron M. C. Herings, Hubert G. M. Leufkens, Ronald P. Stolk
Publikováno v:
Erkens, J A, Herings, R M, Stolk, R P, Spoelstra, J A, Grobbee, D E & Leufkens, H G 2002, ' Cardiovascular risk factors and diseases precede oral hypoglycaemic therapy in patients with type 2 diabetes mellitus ', Journal of Clinical Epidemiology, vol. 55, no. 4, pp. 345-349 . https://doi.org/10.1016/s0895-4356(01)00482-6
Journal of Clinical Epidemiology, 55(4), 345-349. Elsevier USA
Journal of Clinical Epidemiology, 55(4), 345-349. Elsevier USA
Although patients with type 2 diabetes mellitus and cardiovascular disease share common risk factors, the link between these diseases remains largely unexplained. In this case-control study, the earlier use of cardiovascular drugs (before the diagnos